Exosens Statistics
Total Valuation
Exosens has a market cap or net worth of EUR 3.31 billion. The enterprise value is 3.50 billion.
| Market Cap | 3.31B |
| Enterprise Value | 3.50B |
Important Dates
The next confirmed earnings date is Tuesday, July 28, 2026.
| Earnings Date | Jul 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Exosens has 50.70 million shares outstanding. The number of shares has decreased by -0.07% in one year.
| Current Share Class | 50.70M |
| Shares Outstanding | 50.70M |
| Shares Change (YoY) | -0.07% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.58% |
| Owned by Institutions (%) | 26.97% |
| Float | 30.36M |
Valuation Ratios
The trailing PE ratio is 47.19 and the forward PE ratio is 34.35. Exosens's PEG ratio is 2.12.
| PE Ratio | 47.19 |
| Forward PE | 34.35 |
| PS Ratio | 7.06 |
| PB Ratio | 7.42 |
| P/TBV Ratio | 49.93 |
| P/FCF Ratio | 66.21 |
| P/OCF Ratio | 33.05 |
| PEG Ratio | 2.12 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 26.28, with an EV/FCF ratio of 70.17.
| EV / Earnings | 82.01 |
| EV / Sales | 7.48 |
| EV / EBITDA | 26.28 |
| EV / EBIT | 33.65 |
| EV / FCF | 70.17 |
Financial Position
The company has a current ratio of 2.46, with a Debt / Equity ratio of 0.60.
| Current Ratio | 2.46 |
| Quick Ratio | 1.54 |
| Debt / Equity | 0.60 |
| Debt / EBITDA | 2.00 |
| Debt / FCF | 5.34 |
| Interest Coverage | 8.61 |
Financial Efficiency
Return on equity (ROE) is 16.36% and return on invested capital (ROIC) is 13.24%.
| Return on Equity (ROE) | 16.36% |
| Return on Assets (ROA) | 7.67% |
| Return on Invested Capital (ROIC) | 13.24% |
| Return on Capital Employed (ROCE) | 13.60% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 312,333 |
| Profits Per Employee | 28,496 |
| Employee Count | 1,499 |
| Asset Turnover | 0.55 |
| Inventory Turnover | 1.89 |
Taxes
In the past 12 months, Exosens has paid 17.99 million in taxes.
| Income Tax | 17.99M |
| Effective Tax Rate | 20.40% |
Stock Price Statistics
The stock price has increased by +89.48% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +89.48% |
| 50-Day Moving Average | 60.42 |
| 200-Day Moving Average | 48.30 |
| Relative Strength Index (RSI) | 54.53 |
| Average Volume (20 Days) | 163,431 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Exosens had revenue of EUR 468.19 million and earned 42.72 million in profits. Earnings per share was 0.84.
| Revenue | 468.19M |
| Gross Profit | 281.19M |
| Operating Income | 104.10M |
| Pretax Income | 88.18M |
| Net Income | 42.72M |
| EBITDA | 128.97M |
| EBIT | 104.10M |
| Earnings Per Share (EPS) | 0.84 |
Balance Sheet
The company has 68.63 million in cash and 266.47 million in debt, with a net cash position of -197.84 million or -3.90 per share.
| Cash & Cash Equivalents | 68.63M |
| Total Debt | 266.47M |
| Net Cash | -197.84M |
| Net Cash Per Share | -3.90 |
| Equity (Book Value) | 445.65M |
| Book Value Per Share | 8.79 |
| Working Capital | 166.53M |
Cash Flow
In the last 12 months, operating cash flow was 100.00 million and capital expenditures -50.07 million, giving a free cash flow of 49.93 million.
| Operating Cash Flow | 100.00M |
| Capital Expenditures | -50.07M |
| Depreciation & Amortization | 24.87M |
| Net Borrowing | -5.63M |
| Free Cash Flow | 49.93M |
| FCF Per Share | 0.98 |
Margins
Gross margin is 60.06%, with operating and profit margins of 22.24% and 9.12%.
| Gross Margin | 60.06% |
| Operating Margin | 22.24% |
| Pretax Margin | 18.83% |
| Profit Margin | 9.12% |
| EBITDA Margin | 27.55% |
| EBIT Margin | 22.24% |
| FCF Margin | 10.66% |
Dividends & Yields
This stock pays an annual dividend of 0.30, which amounts to a dividend yield of 0.46%.
| Dividend Per Share | 0.30 |
| Dividend Yield | 0.46% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 11.89% |
| Buyback Yield | 0.07% |
| Shareholder Yield | 0.53% |
| Earnings Yield | 1.29% |
| FCF Yield | 1.51% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Exosens has an Altman Z-Score of 3.95 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.95 |
| Piotroski F-Score | 6 |